PACMILIMAB
UNII ZXP96ZI2RA

Substance Identification & Data

This profile provides standardized clinical and technical data for Pacmilimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) ZXP96ZI2RA.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2145091-51-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

ZXP96ZI2RA

CAS Registry Number

2145091-51-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

PACMILIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C132192

National Cancer Institute reference terminology for clinical and research data.

INN ID

10938

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

HI-170

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Pacmilimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

PACMILIMAB

Common Names & Synonyms

IMMUNOGLOBULIN G4, ANTI-(HUMAN PROGRAMMED CELL DEATH-LIGAND 1) (HUMAN MONOCLONAL CX-072 .GAMMA.4-CHAIN), DISULFIDE WITH PRODOMAIN PROTEIN (SYNTHETIC MASKING MOIETY AND CLEAVABLE MOIETY PROTEASE SUBSTRATE-CONTAINING) FUSION PROTEIN WITH HUMAN MONOCLONAL CX-072 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS PROGRAMMED CELL DEATH 1 LIGAND 1 (PDCD1 LIGAND 1, B7 HOMOLOG 1, CD274 ANTIGEN))HOMO SAPIENS MONOCLONAL ANTIBODY.GAMMA.4 HEAVY CHAIN (1-442) (VH (HOMO SAPIENS IGHV3-23*03 (93%) (IGHD)-IGHJ4*01) (8.8.9) (1-116)-HOMO SAPIENS IGHG4*01 (HINGE(S10>P(224)), CH3(K107>DEL(443))) (117-442)), (130-264')-DISULFIDE WITH .KAPPA. LIGHT CHAIN (1'-264') (N-TERMINAL REGION ''MASK'' (1'-21')-TRIGLYCYLDISERYLDIGLYCYLBIS(SERYLDIGLYCYL) LINKER (22'-34') PROTEASE CLEAVABLE REGION (35'-47') DIGLYCYLSERYL LINKER (48'-50') V-KAPPA (HOMO SAPIENS IGKV1-39*01 (96%) IGKJ4*01)(6.3.9) (51'-157')-HOMO SAPIENS IGKC*01(158'-264')), DIMER (222-222'':225-225'')-BISDISULFIDE

PACMILIMAB [INN]

PACMILIMAB [USAN]

PACMILIMAB [WHO-DD]

PROTEASE-ACTIVATED ANTI-PD-L1 ANTIBODY PRODRUG CX-072